PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

Mohummad Minhaj Siddiqui, Soroush Rais‐Bahrami, Barış Türkbey et al. · JAMA · 2015 · 1.5K citations · Full text

Medicine, Oncology, Urology +17

A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy

Eduard Baco, Erik Rud, Lars Magne Eri et al. · European Urology · 2015 · 253 citations · Full text

Medicine, Radiology, Urology +17

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Tobias Nordström, Olof Akre, Markus Aly et al. · Prostate Cancer and Prostatic Diseases · 2017 · 243 citations

Medicine, Oncology, Urology +16

Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study

Valeria Panebianco, Flavio Barchetti, Alessandro Sciarra et al. · Urologic Oncology Seminars and Original Investigations · 2014 · 241 citations

Medicine, Radiology, Urology +17